0-4℃ for short term (days to weeks), or -20℃ for long term (months).
Urethane was an antineoplastic agent .Now is used for other medicinal purposes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | 20.00 | |
100 mg | In stock | 33.00 | |
200 mg | In stock | 42.00 | |
250 mg | In stock | 45.00 | |
500 mg | In stock | 50.00 | |
1 g | In stock | 59.00 | |
1 mL * 10 mM (in DMSO) | In stock | 54.00 |
Description | Urethane was an antineoplastic agent .Now is used for other medicinal purposes. |
Targets&IC50 | AMPA :ic50 34mM(EC50), GABAR :ic50 64mM(EC50), glycine receptors :ic50 46mM(EC50), NMDA receptor :ic50 70mM(EC50), α4β2 nAChR :ic50 114mM(EC50), |
In vivo | Urethane, a carcinogenic substance, is favored for acute in vivo electrophysiological experiments because it induces long-lasting steady level of anesthesia with muscle relaxation and minimally affects the autonomic and cardiovascular systems[2]. Urethane affects both inhibitory and excitatory systems but the magnitude of the alterations is less than that produced by other more selective anesthetics[3]. But also, Urethane anesthesia is usually restricted to terminal (acute) experiments due to its potential long-term toxicity[1]. |
Synonyms | Ethyl carbamate , Ethylurethane , Carbamic acid ethyl ester |
Purity | 99.63% |
Molecular Weight | 89.09 |
Formula | C3H7NO2 |
CAS No. | 51-79-6 |
0-4℃ for short term (days to weeks), or -20℃ for long term (months).
DMSO: 125 mg/mL (1403.08 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.